United-Guardian, Inc. (NASDAQ:UG – Get Free Report) shares passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $8.24 and traded as low as $8.15. United-Guardian shares last traded at $8.20, with a volume of 2,968 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen initiated coverage on United-Guardian in a research note on Thursday, May 15th. They issued a “buy” rating on the stock.
Read Our Latest Analysis on United-Guardian
United-Guardian Trading Down 1.3%
United-Guardian (NASDAQ:UG – Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.12 earnings per share (EPS) for the quarter. United-Guardian had a return on equity of 30.25% and a net margin of 28.30%. The business had revenue of $2.48 million for the quarter.
Hedge Funds Weigh In On United-Guardian
Institutional investors and hedge funds have recently modified their holdings of the stock. Northern Trust Corp boosted its holdings in shares of United-Guardian by 69.5% in the 4th quarter. Northern Trust Corp now owns 25,527 shares of the company’s stock worth $244,000 after purchasing an additional 10,466 shares during the period. Renaissance Technologies LLC boosted its holdings in shares of United-Guardian by 4.3% in the 4th quarter. Renaissance Technologies LLC now owns 190,163 shares of the company’s stock worth $1,818,000 after purchasing an additional 7,800 shares during the period. Heron Bay Capital Management purchased a new position in shares of United-Guardian in the 4th quarter worth approximately $135,000. Geode Capital Management LLC boosted its holdings in shares of United-Guardian by 10.3% in the 4th quarter. Geode Capital Management LLC now owns 31,264 shares of the company’s stock worth $302,000 after purchasing an additional 2,929 shares during the period. Finally, United Capital Financial Advisors LLC purchased a new position in shares of United-Guardian in the 4th quarter worth approximately $192,000. Hedge funds and other institutional investors own 23.16% of the company’s stock.
United-Guardian Company Profile
United-Guardian, Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries.
Read More
- Five stocks we like better than United-Guardian
- How to Plot Fibonacci Price Inflection Levels
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- 3 Stocks Set to Double—And There’s Still Time to Buy
- Investing In Automotive Stocks
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for United-Guardian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United-Guardian and related companies with MarketBeat.com's FREE daily email newsletter.